Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8+ T Cells in Non-small Cell Lung Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8+ T Cells in Non-small Cell Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-18
DOI
10.3389/fonc.2018.00631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo
- (2018) Yanting Yang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Scaffold diversity-oriented synthesis of limonoid dimers: discovery of an axially chiral agent with in vivo anti-breast cancer activity
- (2018) Wan-Shan Li et al. Organic Chemistry Frontiers
- MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR
- (2017) Jiao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade
- (2017) Thomas B. Huffaker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1
- (2017) Pei Li et al. Journal of Hematology & Oncology
- Anti-inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells
- (2017) Ailing Ma et al. Molecular Medicine Reports
- T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
- (2017) Xiuxiu Sang et al. Acta Pharmaceutica Sinica B
- Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
- (2017) Guangyao Lv et al. Acta Pharmaceutica Sinica B
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- Roles of regulatory T cells in cancer immunity
- (2016) Yoshiko Takeuchi et al. INTERNATIONAL IMMUNOLOGY
- Targeting microRNAs as key modulators of tumor immune response
- (2016) Laura Paladini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- microRNA-155 deficiency impairs dendritic cell function in breast cancer
- (2016) Junfeng Wang et al. OncoImmunology
- The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
- (2016) Alexander S. Baras et al. OncoImmunology
- Recent Advances in Immunotherapy in Metastatic NSCLC
- (2016) Pranshu Bansal et al. Frontiers in Oncology
- Regulatory T cells and potential inmmunotherapeutic targets in lung cancer
- (2015) Ding Zhang et al. CANCER AND METASTASIS REVIEWS
- Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer
- (2015) V. K. Anagnostou et al. CLINICAL CANCER RESEARCH
- CD8+ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity
- (2015) G Elizabeth Pluhar et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
- (2015) Qi-Wei Jiang et al. MEDICINAL RESEARCH REVIEWS
- Refining the treatment of NSCLC according to histological and molecular subtypes
- (2015) Anish Thomas et al. Nature Reviews Clinical Oncology
- Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine
- (2015) Qi-Wei Jiang et al. Oncotarget
- Oxymatrine Lightened the Inflammatory Response of LPS-Induced Mastitis in Mice Through Affecting NF-κB and MAPKs Signaling Pathways
- (2014) Zhengtao Yang et al. INFLAMMATION
- MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth
- (2014) Junfeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Optimizing lung cancer treatment approaches
- (2014) Rafael Rosell et al. Nature Reviews Clinical Oncology
- Therapeutic targeting of microRNAs: current status and future challenges
- (2014) Zhonghan Li et al. NATURE REVIEWS DRUG DISCOVERY
- miR-155 augments CD8+T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γccytokines
- (2014) Yun Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-tumor activities of matrine and oxymatrine: literature review
- (2014) Yan Liu et al. TUMOR BIOLOGY
- Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
- (2014) Normand Blais et al. Frontiers in Oncology
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mir-155, a central modulator of T-cell responses
- (2013) Evan F. Lind et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- miR-155: an ancient regulator of the immune system
- (2013) Elena Vigorito et al. IMMUNOLOGICAL REVIEWS
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
- (2012) Hui Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer
- (2012) Himashinie V.K. Diyabalanage et al. CANCER LETTERS
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity
- (2012) Thomas B. Huffaker et al. Cell Reports
- Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function
- (2011) I. Dunand-Sauthier et al. BLOOD
- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- CD8+ T Cells: Foot Soldiers of the Immune System
- (2011) Nu Zhang et al. IMMUNITY
- Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer
- (2010) Zhengbin Shen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
- (2010) Shumin Zhang et al. Molecular Cancer
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started